Influence of Fibrinogen Degradation Products (FDP) on Platelet Aggregation, Adhesiveness and Viscous Metamorphosis

E Kowalski; M Kopeć; Z Wegrzynowicz

doi:10.1055/s-0038-1654794

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1963; 10(02): 406-423
DOI: 10.1055/s-0038-1654794

Originalarbeiten — Original Article — Travaux Originaux

Schattauer GmbH

Influence of Fibrinogen Degradation Products (FDP) on Platelet Aggregation, Adhesiveness and Viscous Metamorphosis

Autoren

E Kowalski

¹Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw
M Kopeć

¹Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw
Z Wegrzynowicz

¹Department of Radiobiology and Health Protection, Institute of Nuclear Research, Warsaw

Abstract

Summary

Influence of SKPL on platelet function tests has been studied.

1. Human platelets suspended in borate buffer lose after SKPL treatment the ability to aggregate under the influence of thrombin, ADP and connective tissue extract.

2. Washed platelets incubated with SKPL did not influence the thrombin time of prothrombin free plasma.

3. The digestion of platelet rich plasma with SKPL diminished the ability of platelets to aggregate under the influence of thrombin, ADP and connective tissue extract and the adhesiveness to glass.

4. Viscous metamorphosis after addition of thrombin or ADP was delayed and less advanced in SKPL treated platelet rich plasma as compared with control undigested plasma.

5. The addition of FDP preparation to platelet suspension or to platelet rich plasma impaired their ability to aggregate under the influence of thrombin, ADP and connective tissue extract.

6. Adhesiveness of platelets to glass in the whole blood containing FDP was decreased in comparison with controls.

7. FDP inhibits also the adhesion of platelets from platelet rich plasma to connective tissue fibers (collagen).

8. Viscous metamorphosis induced by thrombin, ADP or connective tissue extract in platelet rich plasma could be delayed or inhibited by addition of FDP.

9. Inhibiting effect of FDP on platelet functions were dependent on concentration of FDP and aggregating agent. FDP influence platelet functions in such concentration which inhibit significantly the thrombin time. Increase of the concentration of the inducing agent can overcome the inhibitory effects of FDP.

10. The significance of the described findings for the hemostatic function of platelets is discussed.

Volltext

Referenzen

References
1 Niewiarowski S, Kowalski E. Un nouvel anticoagulant dérivé du fibrinogène. Rev. hémat. 13: 320 1958;
2 Kowarzyk A, Siwiñska-Koczy M, Głogowska J, Czerwiñska P. O antytrombinowym produkcie fibrynogenolizy i fibrinolizy. Postçpy Hig. Med. dosw. 12: 303 1958;
3 Triantaphylopoulos D. C. Nature of the thrombin-inhibiting effect of incubated fibrinogen. Amer. J. Med. 197: 575 1959;
4 Kowalski E. Fibrinogen derived inhibitors of blood coagulation. In New Blood Clotting Factors. Thrombos. Diathes. haemorrh. (Stuttg.) (Suppl) 04: 211 1960;
5 Kopec M, Kowalski E, Stachurska J. Studies on paracoagulation. Role of antithrombin. VI. Thrombos. Diathes. haemorrh. (Stuttg) 05: 285 1960;
6 Kowarzyk H, Glogowska I, Szymik S. The enzymatic action of thrombin and the physical phase of fibrin clotting. Arch. Immunol. Ter. dosw. 09: 341 1961;
7 LataHo Z. S, Fletcher A. P, Alkjaersig N, Sherry S. Inhibition of fibrin polymerization by fibrinogen proteolysis products. Amer. J. Physiol. 202: 681 1962;
8 LataHo Z. S, Fletcher A. P, Alkjaersig N, Sherry S. Influence of pH, ionic strength, neutral ions and thrombin on fibrin polymerization. Amer. J. Physiol. 202: 675 1962;
9 Fletcher A. P, Alkjaersig N, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. J. clin. Invest. 41: 896 1962;
10 Alkjaersig N, Fletcher A. P, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. II. The significance, mechanism and consequences of defective fibrin polymerization. T. clin. Invest. 41: 917 1962;
11 Bang N. U, Fletcher A. P, Alkjaersig N, Sherry S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic (“fibrinolytic”) states. III. Demonstration of abnormal clot structure by electron microscopy. J. clin. Invest. 41: 935 1962;
12 Roskam J. Role of platelets in the formation of a hemostatic plug. In Blood Platelets. Henry Ford Hospital Symposium, 153 Little: Brown and Company; Boston: (Mass.) 1961
13 Roskam J, Hugues J, Bounameaux Y. L’hémostase spontané, étude synthétique et analytique. J. Physiol. 53: 175 1961;
14 Lüscher E. F. Hémostase spontané, thrombose et coagulation sanguine. Proceedings 2nd Symposium de la Fondation Valentino Baldacci, Pisa. Omnia med. (Pisa) 202 1957;
15 Owren P. A. Blood coagulation and spontaneous hemostasis. Proc. Intern. Union Physiol. Sci. XXII Intern. Congress Leiden, I, 227, 1962 Excerpta Medica Found; Amsterdam, London, Milan, New York: 1962
16 Zucker M. B. General observations on hemostasis. Proc. Intern. Union Physiol. Sci. XXII Intern. Congress Leiden, I, 219, 1962 Excerpta Medica Found; Amsterdam, London, Milan, New York: 1962
17 Mason Jr. R. G. Pathogenesis of thrombosis: platelet contribution. Science 16: 833 1962;
18 Zucker M. B. Platelet agglutination and vasoconstriction as factors in spontaneous hemostasis in normal, thrombocytopenic, heparinized and hypothrombinemic rats. Amer. J. Physiol. 148: 275 1947;
19 Hugues J. Contribution à l’étude des facteurs vasculaires et sanguines dans l’hémostase spontanée. Arch. int. Physiol. 61: 565 1953;
20 Hugues J. Métamorphose visqueuse des plaquettes et formation du clou hémostatique. Thrombos. Diathes. haemorrh. (Stuttg) 03: 34 1959;
21 Hugues J. Agglutination précoce des plaquettes au cours de la formation du clou hémostatique. Thrombos. Diathes. haemorrh. (Stuttg) 03: 177 1959;
22 Fonio A. Untersuchungen der Thrombozyten im Dunkelfeld-Nativpräparat. Vorläufige Mitteilung. Schweiz, med. Wschr. 1939; 952.
23 Bounameaux Y. Thrombine et agglutination plaquettaire. Arch. int. Physiol. 63: 243 1955;
24 Lüscher E. F. Viscous metamorphosis of blood platelets and clot retraction. Vox Sang. (Basel) 01: 133 1956;
25 Bounameaux Y. Recherches sur le méchanisme de la retraction du caillot et de la métamorphose visqueuse des plaquettes. Rev. hémat. 12: 16 1957;
26 Shermer R. W, Mason R. G, Wagner R. H, Brinkhous K. M. Studies on thrombin induced platelet agglutination. J. exp. Med. 114: 905 1961;
27 Schmid H. J, Jackson D. P, Conley C. L. Mechanism of action of thrombin on platelets. J. clin. Invest. 41: 543 1962;
28 Gaarder A, Jonsen J, Laland S, Hellem A, Owren P. A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 192: 531 1961;
29 Gaarder A. M, Laland S. The chemical nature of the platelet adhesiveness factor (factor R of Hellem). Proc. VIIIth Congr. Europ. Soc. Haematol. Vienna. 1961. No. 361. Karger, Basel: 1962.
30 Käser-Glanzmann Lüscher E. F. The mechanism of platelet aggregation in relation to hemostasis. Thrombos. Diathes. haemorrh. (Stuttg) 07: 480 1962;
31 O’Brien J. R. Platelet aggregation. Part I. Some effects of the adenosine phosphates, thrombin and cocaine upon platelet adhesiveness. J. clin. Path. 15: 446 1962;
32 Born G. V.. R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927 1962;
33 Bounameaux Y. L’accolement des plaquettes aux fibres sous-endothéliales. C. R. Soc. Biol. (Paris) 153: 865 1959;
34 Zucker M. B, Borelli J. Platelet dumping produced by connective tissue suspension and by collagen. Proc. Soc. exp. Biol. (N. Y) 109: 779 1962;
35 Kekwick R. A, Mackay M. E, Nance M. H, Record B. R. The purification of human fibrinogen. Biochem. J. 60: 671 1955;
36 Blombäck B. B, Yamashina S. On the N-terminal amino acids in fibrinogen and fibrin. Ark. Kemi. 12: 299 1958;
37 Kline D. L. The purification and cristallization of plasminogen (profibrinolysin). J. biol. Chem. 204: 949 1953;
38 Hagan J. J, Ablondi F. B, Renso E. C. Purification and biochemical properties of human plasminogen. J. biol. Chem. 235: 1005 1960;
39 Spaet T. H, Citron J, Spivack M. Some properties of the platelet-connective tissue mixed agglutination reaction. Proc. Soc. exp. Biol. (N. Y) 111: 292 1962;
40 O’Brien J. R. The adhesiveness of native platelets and its prevention. J. clin. Path. 14: 140 1961;
41 Nygaard K. K. A direct method of counting platelets in oxalated plasma. Proc. Mayo Clin. 08: 365 1933;
42 Hellem A. J. The adhesiveness of human blood platelets in vitro. Scand. J. clin. Lab. Invest. (Suppl.) 12. 51.
43 Lüscher E. F. Thrombozytenfaktoren. Ergebn. Physiol. 50: 1 1959;
44 Johnson S. A, Schneider C. L. The existence of antifibrinolysin activity in platelets. Science 117: 229 1953;
45 Seligman M, Goudeman B, Janin A, Bernard J, Grabar P. Étude immunochimiques sur la présence de fibrinogène dans des extraits de plaquettes humaines lavées et dans certains extraits leucocytaires. Rev. Hémat. 12: 302 1957;
46 Salmon J, Bounameaux Y. Situation du fibrinogène de cell dans les thrombocytes bovins isolés et lavés. Arch. int. Physiol. 65: 502 1957;
47 Johnson S. A, McKenna J. L. An investigation of the possible role of platelet fibrinogen in thrombin formation. Thrombos. Diathes. haemorrh. (Stuttg) 09: 102 1963;
48 Grelle K. The mechanism of thrombin-catalysed hemostatic reactions in blood platelets. Norwegian Univ. Press; Oslo: 1962
49 Liischer E. F, Bettex-Galland M. Biochemical aspects of viscous metamorphosis. Proc. Intern. Union Physiol. Sci. XXII Intern. Congress Leiden 1962. Excerpta Medica Foundation Amsterdam, London, Milan, New York. I: 229 1962;
50 Casai P, Graafland R, Izaru P, Mathieu M, Paleirac G, Fischer J. Hémorrhagies thrombocytopéniques arrêtées par injections intravéneuses de fibrinogène humain. Sang. 27: 84 1956;
51 Salmon J. Inhibition du purpura thrombopénique immunologique par l’acide 8-amino- caproic. Thrombos. Diathes. haemorrh. (Stuttg) 06: 172 1961;
52 Salmon J, Hugues J, Smoliar V. Purpura thrombopénique de la nature immunologique. Thrombos. Diathes. haemorrh. (Stuttg) 07: 457 1962;
53 Salmon J. La lésion vasculaire dans la purpura thrombopénique. Bull. Acad. roy. Méd. Belg. (Sér. VII) 02: 113 1962;